<DOC>
	<DOCNO>NCT01735357</DOCNO>
	<brief_summary>The purpose study determine whether supplementation oil enrich long chain n-3 PUFA , either EPA DHA , differential effect platelet , endothelial vascular function .</brief_summary>
	<brief_title>Differential Effects Eicosapentaenoic Acid ( EPA ) Docosahexaenoic Acid ( DHA ) Platelet , Endothelial Vascular Function</brief_title>
	<detailed_description>Relatively study make head-to-head comparison DHA ( 22:6n-3 ) EPA ( 20:5n-3 ) . The understanding differential effect may great interest population low EPA intake vegetarian , may choose supplement dietary intake long-chain n-3 PUFA form DHA-rich algal oil . This study aim investigate effect supplementation oil rich either EPA DHA ( 3g/day , 6 week ) healthy young male platelet , endothelial vascular function , well CVD risk factor . The primary outcome platelet monocyte aggregate endothelial progenitor cell - novel marker platelet endothelial function , measure flow cytometry , Secondary outcomes include capillary density , measure capillaroscopy ass change microvascular function , pulse wave analysis , digital volume pulse ambulatory blood pressure . Other secondary outcome include lipid profile ( TAG , cholesterol , NEFA ) , glycaemic control ( HOMA , QUICKI ) oxidative stress ( isoprostane ) . The omega-3 index ( erythrocyte EPA+DHA ) use marker compliance .</detailed_description>
	<criteria>Healthy males No smoker Aged 1845y old Able understand information sheet comply trial procedure Having give write consent take part study prior participation . Reported history CVD ( myocardial infarction , angina , venous thrombosis , stroke , dyslipidemia ) , diabetes ( fast glucose â‰¥ 6.1 mmol/L ) , cancer , kidney , liver bowel disease . Presence gastrointestinal disorder use drug , likely alter gastrointestinal motility nutrient absorption . Current smoker ; history substance abuse alcoholism ( previous weekly alcohol intake &gt; 60 units/week ) ; current selfreported weekly alcohol intake exceed 28 unit Recent use hypolipidaemic , antihypertensive , antiplatelet antithrombotic mediation Platelet count normal range history indicative congenital acquire platelet haemostatic defect . Allergy intolerance component study capsule Unwilling restrict consumption source fish oil length study Subjects reporting consumption &gt; 1 portion oily fish per week Weight change &gt; 3 kg precede 2 month ; BMI &lt; 18 &gt; 32 kg/m2 Blood pressure &gt; 160/90 mmHg Fasting blood cholesterol &gt; 6.5 mmol/L ; fast triacylglycerol concentration &gt; 2.0 mmol/L</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Eicosapentaenoic acid</keyword>
	<keyword>Docosahexaenoic acid</keyword>
	<keyword>Cardiovascular risk</keyword>
	<keyword>Platelet function</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Vascular function</keyword>
	<keyword>young male</keyword>
</DOC>